These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1721960)

  • 1. [Determination of the circulating antibodies to cardiomyocyte membrane proteins based on the immunoblotting principle].
    Tereshchenko SE; Riazanov SL; Zimin IuI; Kotelevtsev IuV
    Lab Delo; 1991; (9):54-6. PubMed ID: 1721960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of the presence of anti-heart antibodies in some cardiopathies].
    Barabino A; Di Benedetto G; Indiveri F; Merello MA; Puppo F; Soldà AM
    Arch Maragliano Patol Clin; 1974; 30(1):23-9. PubMed ID: 4480695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic disorders in noncoronary diseases of the myocardium].
    Rukosuev VS; Moiseev VS; Shelepin AA; Ogurtsov PP; Nanaev AK
    Klin Med (Mosk); 1988 Aug; 66(8):71-5. PubMed ID: 3193738
    [No Abstract]   [Full Text] [Related]  

  • 4. [The viral and immunological characteristics of cardiomyopathies and myocarditis].
    Moiseev VS; Ogurtsov PP; Traianova TG; Savinov AP; Lavrova IK; Stepina VN; Shelepin AA; Rukosuev VS; Tereshchenko SE; Korovina EA
    Ter Arkh; 1990; 62(8):77-82. PubMed ID: 2274878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of endothelial cell membrane proteins that bind anti-DNA antibodies from patients with systemic lupus erythematosus by direct or indirect mechanisms.
    Chan TM; Cheng IK
    J Autoimmun; 1997 Oct; 10(5):433-9. PubMed ID: 9376070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pathogenic role of cell-surface polypeptides, cross-reactive with DNA, in systemic lupus erythematosus.
    Jacob L; Kerjaschki D; Viard JP; Lety MA; Primo J; Binder S; Sahuquillo C; Bach JF; Louvard D
    Nephrologie; 1989; 10(3):139-40. PubMed ID: 2691910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anti-heart antibody in sera from patients with myocarditis or myocardiopathy by use of microcalorimetry.
    Shingu M; Shingu M
    Tokai J Exp Clin Med; 1990 Sep; 15(5):353-61. PubMed ID: 2131640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic aspects of heart disease].
    Trezza E
    Arq Bras Cardiol; 1978 Oct; 31(5):329-40. PubMed ID: 106809
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological examinations in dilated cardiomyopathies].
    Bolte HD; Fischer S; Ludwig B
    Z Kardiol; 1982 Aug; 71(8):517-21. PubMed ID: 6215779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus associated with antiribosomal P protein antibody.
    Takehara K; Nojima Y; Kikuchi K; Igarashi A; Soma Y; Tsuchida T; Ishibashi Y
    Arch Dermatol; 1990 Sep; 126(9):1184-6. PubMed ID: 2204307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus.
    Miyoshi Y; Kilpatrick KA; Kelley RO; Searles RP; Williams RC
    J Rheumatol; 1985 Dec; 12(6):1097-104. PubMed ID: 4093915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating immune complexes in cutaneous disease using a monoclonal rheumatoid factor hemagglutination method.
    Jordon RE; Mackel SE; Brumfield H
    J Clin Lab Immunol; 1981 Jul; 6(1):87-90. PubMed ID: 6790707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-organ antibodies in patients with systemic lupus erythematosus.
    Wierzchowiecki M; Zeromski J; Gluszek J; Kozlowski W
    Pol Med J; 1969; 8(6):1288-91. PubMed ID: 4905665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenic mechanism of anti-sarcolemma antibodies in primary cardiomyopathies].
    Sack W; Wachsmuth ED
    Verh Dtsch Ges Inn Med; 1974; 80():1210-2. PubMed ID: 4454377
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus.
    Sköldberg F; Rönnblom L; Thornemo M; Lindahl A; Bird PI; Rorsman F; Kämpe O; Landgren E
    Biochem Biophys Res Commun; 2002 Mar; 291(4):951-8. PubMed ID: 11866458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.